🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

10 recruiting trials

for Relapsing-remitting Multiple Sclerosis (RRMS)

A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis NCT07189325Phase 31 site📍 Montpellier University Hospital, Montpellier · Tests: Platform therapies (Dimethyl Fumarate, Teriflunomide, Glatiramer Acetate, Beta-interferons), Anti-CD20 therapies (Ocrel… ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS NCT06733922Phase 414 sites📍 Calgary📍 Calgary📍 Edmonton Novartis Pharmaceuticals · Tests: ETNATM-ProgMS Indole-3-PROpionic Acid Clinical Trials - Multiple Sclerosis NCT07318129NA1 site📍 Glostrup Municipality Glostrup University Hospital, Copenhagen · Tests: Placebo, Indole-3-propionic acid (IPA) A Study of the Efficacy and Safety of BCD-281 in Patients With Relapsing-Remitting Multiple Sclerosis NCT07321093Phase 31 site📍 Nizhny Novgorod Biocad · Tests: BCD-281, Ocrelizumab Imaging the Interplay Between Axonal Damage and Repair in Multiple Sclerosis NCT05177523n/a1 site📍 Basel University Hospital, Basel, Switzerland · Tests: MRI, Neurocognitive examination for healthy subjects, blood sampling Monthly Monitoring of Plasma NfL in Treated Relapsing-remitting Multiple Sclerosis to Detect Persistent Infraclinical Disease Activity NCT07292480NA2 sites📍 Nice📍 Nîmes Centre Hospitalier Universitaire de Nīmes · Tests: Monthly pNfL monitoring RRMS: Disease PROgression and Myeloid Profiling After Bone Marrow TRANSPLANTation and Second Line Therapies NCT06267781n/a1 site📍 Milan IRCCS San Raffaele TOTEM RRMS : TestOsterone TreatmEnt on Neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis NCT03910738Phase 25 sites📍 Besançon📍 Nancy📍 Paris University Hospital, Strasbourg, France · Tests: Nebido® Testosterone Undecanoate 1000 Mg/4 mL Solution for Injection, Placebo 4 mL Solution for Injection, MRI, Assessm… Hyperpolarized Carbon Metabolic Imaging in Multiple Sclerosis NCT07510607Phase 21 site📍 San Francisco Ari Green · Tests: HP 13C pyruvate injection, MRI Scanner A Study of Rocbrutinib in PRL-Positive Relapsing-Remitting Multiple Sclerosis NCT07776743Phase 21 site📍 Beijing Guangzhou Lupeng Pharmaceutical Company LTD. · Tests: Rocbrutinib, Dimethyl Fumarate
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy